EuBiologics Co., Ltd. (206650.KQ)
KRW 11100.0
(-0.54%)
KRW 11100.0
(-0.54%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 13.34 Billion KRW | -25.93% |
| 2022 | 18.01 Billion KRW | 21.9% |
| 2021 | 14.77 Billion KRW | 59.71% |
| 2020 | 9.25 Billion KRW | 20.65% |
| 2019 | 7.66 Billion KRW | 68.9% |
| 2018 | 4.54 Billion KRW | -0.3% |
| 2017 | 4.55 Billion KRW | -4.81% |
| 2016 | 4.78 Billion KRW | 21.24% |
| 2015 | 3.94 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 16.17 Billion KRW | 21.21% |
| 2024 Q2 | 20.71 Billion KRW | 28.1% |
| 2023 Q2 | 15.29 Billion KRW | -9.38% |
| 2023 Q3 | 16.17 Billion KRW | 5.76% |
| 2023 Q4 | 13.34 Billion KRW | -17.52% |
| 2023 Q1 | 16.87 Billion KRW | -6.31% |
| 2023 FY | 13.34 Billion KRW | -25.93% |
| 2022 Q2 | 21.11 Billion KRW | 7.61% |
| 2022 FY | 18.01 Billion KRW | 21.9% |
| 2022 Q4 | 18.01 Billion KRW | -22.77% |
| 2022 Q3 | 23.32 Billion KRW | 10.46% |
| 2022 Q1 | 19.61 Billion KRW | 32.78% |
| 2021 FY | 14.77 Billion KRW | 59.71% |
| 2021 Q3 | 15.6 Billion KRW | 32.16% |
| 2021 Q2 | 11.8 Billion KRW | 16.21% |
| 2021 Q4 | 14.77 Billion KRW | -5.29% |
| 2021 Q1 | 10.15 Billion KRW | 0.0% |
| 2020 FY | 9.25 Billion KRW | 20.65% |
| 2019 FY | 7.66 Billion KRW | 68.9% |
| 2018 FY | 4.54 Billion KRW | -0.3% |
| 2017 FY | 4.55 Billion KRW | -4.81% |
| 2016 FY | 4.78 Billion KRW | 21.24% |
| 2015 FY | 3.94 Billion KRW | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| HLB Pharmaceutical Co., Ltd | 20.85 Billion KRW | 36.037% |
| CMG Pharmaceutical Co., Ltd. | 15.87 Billion KRW | 15.963% |
| Celltrion Pharm, Inc. | 100.42 Billion KRW | 86.714% |
| Huons Global Co., Ltd. | 121.81 Billion KRW | 89.048% |
| DongKook Pharmaceutical Co., Ltd. | 138.34 Billion KRW | 90.356% |
| Enzychem Lifesciences Corporation | 14.94 Billion KRW | 10.734% |
| Humedix Co., Ltd. | 28.62 Billion KRW | 53.393% |
| Boditech Med Inc. | 31.6 Billion KRW | 57.784% |
| FutureChem Co.,Ltd | 1.37 Billion KRW | -870.642% |
| Huons Co., Ltd. | 76.59 Billion KRW | 82.582% |
| BNC Korea Co., Ltd. | 11.39 Billion KRW | -17.098% |
| AptaBio Therapeutics Inc. | - KRW | -Infinity% |